Located near the University of Strasbourg in France, Polyplus-transfection is a biotech company that offers a range of proprietary reagents for gene, oligonucleotide, and siRNA transfection. With ISO 9001 certification since 2002, they supply their products globally through a distributor network and have been involved in numerous clinical trials. Their extensive patent portfolio includes original methods for therapeutic siRNA delivery. As a leading provider of upstream solutions for biologic and cell/gene therapy production, Polyplus also offers process-centric transfection reagents, kits, and support services. Recently, they expanded their portfolio by integrating custom plasmid vector design to help customers optimize process economics while meeting scientific and regulatory standards. With headquarters in Europe, the company is expanding globally, operating in the United States and Asia.